What is Tribe Clinical Development?
Tribe Clinical Development operates as a specialized Clinical Research Organization (CRO) that bridges the gap between complex clinical trial requirements and efficient execution. By focusing on high-stakes therapeutic areas such as Oncology, Cardiology, and Endocrinology, the company provides essential project management and monitoring services. The organization distinguishes itself through a leadership team comprised of former industry professionals who possess a deep understanding of the regulatory and operational pressures inherent in drug development. Their service-oriented approach is designed to meet the urgent demands of modern clinical trials, ensuring that client objectives are met with precision and professional rigor.
How much funding has Tribe Clinical Development raised?
Tribe Clinical Development has raised a total of $332K across 2 funding rounds:
Debt
$150K
Debt
$182K
Debt (2020): $150K with participation from PPP
Debt (2021): $182K led by PPP
Key Investors in Tribe Clinical Development
PPP
Public-Private Partnership
What's next for Tribe Clinical Development?
With the recent influx of capital, Tribe Clinical Development is poised to accelerate its strategic expansion and deepen its therapeutic expertise. The company is expected to prioritize the scaling of its monitoring infrastructure and the integration of advanced project management technologies to support increasingly complex global trials. As the pharmaceutical sector continues to demand more agile and responsive research partners, Tribe's focus on hard work and client-centric delivery will likely serve as a primary competitive advantage. Future growth will likely involve expanding its footprint in emerging disease areas and strengthening its core service offerings to maintain its status as a reliable partner for biotech innovators.
See full Tribe Clinical Development company page
